Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) have been assigned an average rating of “Moderate Buy” from the nine research firms that are currently covering the stock, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $87.44.
A number of brokerages have issued reports on ACHC. Mizuho cut their price target on shares of Acadia Healthcare from $84.00 to $70.00 and set a “neutral” rating on the stock in a research note on Friday, May 3rd. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $94.00 price target on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Bank of America lowered their price target on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Barclays lowered their price target on Acadia Healthcare from $89.00 to $83.00 and set an “overweight” rating for the company in a report on Thursday, August 1st. Finally, TD Cowen decreased their price objective on Acadia Healthcare from $101.00 to $91.00 and set a “buy” rating for the company in a report on Friday, May 17th.
View Our Latest Analysis on ACHC
Institutional Investors Weigh In On Acadia Healthcare
Acadia Healthcare Trading Down 1.9 %
Shares of ACHC opened at $71.02 on Tuesday. The firm’s fifty day moving average is $67.38 and its two-hundred day moving average is $73.52. The company has a quick ratio of 1.27, a current ratio of 1.18 and a debt-to-equity ratio of 0.60. The stock has a market cap of $6.59 billion, a PE ratio of -507.25, a price-to-earnings-growth ratio of 2.21 and a beta of 1.32. Acadia Healthcare has a 52-week low of $62.04 and a 52-week high of $87.77.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.87 by $0.04. The firm had revenue of $796.00 million for the quarter, compared to analyst estimates of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. Acadia Healthcare’s revenue was up 8.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.92 EPS. Research analysts forecast that Acadia Healthcare will post 3.51 earnings per share for the current fiscal year.
About Acadia Healthcare
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
See Also
- Five stocks we like better than Acadia Healthcare
- There Are Different Types of Stock To Invest In
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- How to Use the MarketBeat Excel Dividend Calculator
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- How to Calculate Stock Profit
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.